LINQ II™ insertable cardiac monitor for cardiac monitoring
The LINQ II™ insertable cardiac monitor (ICM) with AccuRhythm™ AI algorithms is used for long-term heart monitoring.
Download brochure
Overview
Accuracy matters
The LINQ II™ ICM is the most advanced ICM system, featuring enhanced artificial intelligence (AI) algorithms, remote programming, and 4.5-year† longevity.1
LINQ II™ ICM is ideal for patients experiencing infrequent symptoms that require long-term monitoring or ongoing management. AccuRhythm™ AI algorithms are a groundbreaking platform that applies deep learning artificial intelligence algorithms to LINQ II™ data flowing into the CareLink™ network.
† Nominal settings.
Advanced algorithms enabling optimal outcomes
Watch our video to learn more about AccuRhythm™ AI algorithms.
Clinically meaningful and actionable alerts
Developed over one million ECGs, the cloud-based Atrial Fibrilation and Pause AccuRhythm™ AI algorithms enhance the accuracy of LINQ II™ ICM data, reducing false alerts, while retaining true alerts, so you can maintain diagnostic yield and spend more time on the human side of care. 2-4
Reduce false alerts while maintaining sensitivity
AccuRhythm™ AI algorithms further address the two most common sources of these ICM false alerts — AF and Pause.2,3,5
Validation data from real-world LINQ II™ ICM patients demonstrated:
- 97.4% reduction in false Pause alerts.
- 88.2% reduction in false AF alerts.
Preserved true alerts2:
- 99% true AF alerts preserved
- 100% true Pause alerts preserved
91% reduction in LINQ II™ ICM false alerts.
The AccuRhythmTM AI Algorithms can save clinicians approximately 200 hours of false alert review yearly for every 100 LINQ IITM ICM patients. ‡,§,2
‡ The validation study performance and time study results were projected onto 16,301 LINQ II™ patients to calculate the time saved per year in 100 LINQ II™ ICM patients.
§ Estimated time savings was calculated based on 11.3 minutes per non-actionable ICM transmission.6
First ICM with remote programming◊,1
LINQ II ICM enables remote programming capability for all device parameters post-insertion from the clinic, which saves 211 hours per year by reducing alerts and patient face-to-face follow-ups.9
Clinician initiates reprogramming via CareLink™ network.
Monitors act as a pass-through.
Device settings are
automatically updated
without the need for
an office visit.
◊ First European-approved (TÜV-notified body) remote programmable device.
PVC algorithm
The innovative PVC detector may help identify high-risk patients.7,8
Increased connectivity. Seamless experience.
BlueSync™ technology within LINQ II™ ICM enables secure, wireless communication via Bluetooth®* Low Energy without compromising device longevity.1
- Reveal LINQ™ mobile manager
- LINQ II™ device
- MyCareLink Heart™ mobile app on patient’s smartphone or tablet, or
- MyCareLink Relay™ home communicator for bedside use
- CareLink™ network
- BeConnected Patient Service
- FocusOn™ Monitoring & Triaging Service
Effortless connectivity
- Portable Bluetooth®* monitoring
- Monitor automatically detects if new data is available
- Event notification triggers an actionable alert
No manual transmissions
- Remote access to full ECGs eliminates the need for manual transmissions1
- Decreases patient action and confusion
Enhanced patient compliance
- Automatic smartphone notifications help patients stay connected
- Reduces clinic time spent on patient follow-up
MRI conditions for use
LINQ II™ insertable cardiac monitor (ICM) system
Conditionally safe MRI access SureScan™ technology
LINQ II™ ICM is MR Conditional at ≤ 3 T with no post-insertion waiting required.
Additional resources
*® Third-party brands are trademarks of their respective owners.
† Nominal settings.
‡ The validation study performance and time study results were projected onto 16,301 LINQ II™ patients to calculate the time saved per year in 200 LINQ II™ ICM patients.
§ Estimated time savings was calculated based on 11.3 minutes per non-actionable ICM transmission.6
◊ First European-approved (TÜV-notified body) remote programmable device.
1. LINQ II™ LNQ22 ICM clinician manual.
2. Radtke A, Hall M. AccuRhythm™ AI AF & Pause algorithms [white paper]. April 2023. Medtronic data on file.
3. Cheng YJ, Ousdigian KT, Koehler J, Cho YK, Kloosterman M. Innovative artificial intelligence application reduces false Pause alerts while maintaining perfect true Pause sensitivity for insertable cardiac monitors. Presented at HRS 2021.
4. AccuRhythm™ AI clinical manual supplements.
5. Radtke AP, Ousdigian KT, Haddad TD, Koehler JL, Colombowala IK. Artificial intelligence enables dramatic reduction of false atrial fibrillation alerts from insertable cardiac monitors. Heart Rhythm. 2021;18(S8):S47. Presented at HRS 2021.
6. Seiler A, Biundo E. Di Bacco M, et al. Clinic time required for remote and in-person management of patients with cardiac devices: time and motion workflow evaluation. JMIR Cardio. 2021;5(2):e27720. doi: 10.2196/27720.
7. Penela D, Fernández-Armenta J, Aguinaga L, et al. Clinical recognition of pure premature ventricular complex-induced cardiomyopathy at presentation. Heart Rhythm. 2017;14(12):1864–1870. doi: 10.1016/j.hrthm.2017.07.025.
8. Penela D, Van Huls Van Taxis C, Aguinaga L, et al. Neurohormonal, structural, and functional recovery pattern after premature ventricular complex ablation is independent of structural heart disease status in patients with depressed left ventricular ejection fraction: a prospective multicenter study. J Am Coll Cardiol. 2013;62(13):1195–1202. doi: 10.1016/j.jacc.2013.06.012.
9. Seiler A., et al. Utilization of Remote Reprogramming to Manage Insertable Cardiac Monitor Arrhythmia Alert Burden. J Cardiovasc Electrophysiol, 2024.
